Whitehead Warren sold (to issuer) $57 of APTOF
Whitehead Warren sold (to issuer) 33 shares of Aptose Biosciences Inc. (APTOF) at $1.72 on 2026-06-30.
How this was made
The 30-second read
Why it matters
The disclosure confirms an insider sale to the issuer at a specified price and date, but provides no new operational, clinical, or financial catalyst.
Market read
Traders may note the insider reduced holdings, but the transaction size and buyback-style framing suggest limited tradable impact.
What to watch
The filing does not indicate open-market selling intent; the small share count and post-transaction 0 shares reduce the signal-to-noise for traders.
Background
This is an SEC Form 4 insider transaction disclosure for Aptose Biosciences Inc.
Ticker impact
Aptose Biosciences insider Whitehead Warren sold 33 shares to the issuer at $1.72/share, leaving 0 shares after the transaction.
Low likelihood of a sustained price move; any reaction would be small and short-lived.
Form 4 is primary-source, but the transaction is small (33 shares) and described as a sale to the issuer with no 10b5-1 plan, which still typically has limited interpretive power versus larger, open-market trades.
Market effects
No sector read-through; this is a single-company, small insider transaction.
None.
None.
Counterpoint
Because the sale is to the issuer, it may reflect mechanical participation in a corporate action (e.g., buyback) rather than a bearish view.
Key entities
- issuerAptose Biosciences Inc.
Subject of the Form 4 insider transaction; insider sold shares to the issuer at $1.72/share.
- insiderWhitehead Warren
Reported insider who sold 33 shares to the issuer on June 30, 2026.